Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "Calciphylaxis Market Report and Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering.
The calciphylaxis market was valued at USD 3.90 Billion in 2024 driven by the incidence of chronic kidney disease (CKD) across the 8 major markets. The market is expected to grow at a CAGR of 11.59% during the forecast period 2025-2034 and attain a market value of USD 11.68 Billion by 2034. 
Rising Incidence of Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD)
The rising occurrence of CKD and ESRD is increasing the need for calciphylaxis treatment. Calciphylaxis, a serious condition marked by blood vessel calcification in the skin and fat, predominantly impacts individuals with advanced chronic kidney disease and end-stage renal disease. Approximately 37 million Americans, or more than 1 in 7 U.S. adults, are impacted by chronic kidney disease (CKD). In the United States, approximately 550,000 individuals are undergoing dialysis, resulting in an average of nearly 2,000 cases of calciphylaxis occurring annually.
Rising incidence of diabetes and hypertension is also adding to the risk of developing calciphylaxis. This will increase the need for medical treatment along with upgraded methods of diagnosis, and care plans to handle calciphylaxis effectively. Pharmaceutical and medical device companies are also working on developing focused therapies, including novel drugs and wound care items, to improve patient results.
Advancements in Diagnostic Techniques to Address Rising Calciphylaxis Market Demand
Improvements in diagnostic methods have significantly enhanced the capacity to meet the growing needs in the calciphylaxis management. Historically, diagnosing this rare condition with vascular calcification and tissue necrosis has been challenging, but technological advances are now improving the process. High-quality ultrasound, CT angiography, and PET scans offer accurate imaging of calcific deposits in blood vessels, assisting in early detection and treatment preparation.
Combining AI algorithms with imaging methods improves diagnostic precision by detecting subtle patterns. Biomarkers created from proteomic and genomic studies provide extra diagnostic options for medical professionals. These developments speed up diagnosis, customize treatment, and enhance patient results while lowering healthcare expenses. The advancement of diagnostic techniques is transforming the treatment of calciphylaxis to efficiently address market needs.
Calciphylaxis Market Trends
Increasing Awareness About the Condition
Enhanced understanding among healthcare professionals and individuals is resulting in early recognition and treatment, thereby, enhancing patient results and decreasing healthcare expenses. This recognition also promotes the creation of novel treatments and detection instruments.
Epidemiological Studies
Epidemiological research plays a crucial role in the calciphylaxis market by uncovering disease incidence, and potential causes. They assist in recognizing groups that are at high risk of developing the condition. This also influences diagnostics and the allocation of resources. It can also help in shaping healthcare policies.
Therapeutic Advances
The treatment options and outcomes for patients with calciphylaxis are being transformed by therapeutic advances. In the historical period, treatment options were limited, however, advancements in understanding the condition's pathophysiology have resulted in the development of targeted therapies such as sodium thiosulfate. Enhanced wound care and additional therapies have also played a key role in managing symptoms and enhancing patients' quality of life.
Surge in Biomarker Research for Early Detection
Research on biomarkers is crucial for comprehending and treating calciphylaxis. Recognizing biomarkers can enhance diagnosis, forecast results, and create focused treatments. Biomarkers such as increased MGP levels help with early identification and supervision, resulting in timely action.
Key Questions Answered in the Calciphylaxis Market Report
- What was the calciphylaxis market value in 2024?
- What is the calciphylaxis market forecast outlook for 2025-2034?
- What are the regional markets covered in the report?
- What is market segmentation based on treatment type?
- What is the market breakup based on type?
- What is the market segmentation based on end users?
- What are the major factors aiding the calciphylaxis market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints in the market?
- What are the major trends influencing the market?
- Which regional market is expected to dominate the market share in the forecast period?
- Which country is likely to experience elevated growth during the forecast period?
- Who are the key players involved in the calciphylaxis market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 400 |
| Forecast Period | 2025 - 2034 |
| Estimated Market Value (USD) in 2025 | $3.9 Billion |
| Forecasted Market Value (USD) by 2034 | $11.68 Billion |
| Compound Annual Growth Rate | 11.6% |
| Regions Covered | Global |
Supplier Landscape
- Amgen Inc.
- Smith & Nephew plc
- BSN Medical
- Hope Pharmaceuticals, Ltd
- ConvaTec Inc
- Sanifit Therapeutics S.A.
Calciphylaxis Market Segmentation
Market Breakup by Treatment Type
- Drug Therapy
- Hyperbaric Oxygen Therapy
- Surgery
Market Breakup by Type
- Non-Uremic Calciphylaxis
- Uremic Calciphylaxis
Market Breakup by End User
- Hospitals and Clinics
- Homecare
- Others
Market Breakup by Region
- United States
- EU-4 and the United Kingdom
- Japan
- India
For more information about this report visit https://www.researchandmarkets.com/r/won9i3
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
